Search results
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 3 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
CPAP Stock Rockets As Quarterly Report Wipes Out Weight-Loss Woes
Investor's Business Daily· 3 days agoResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss...
Artisan Global Equity Fund Q1 2024 Commentary
Seeking Alpha· 5 days agoArtisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated...
AbbVie Reports First-Quarter 2024 Financial Results
Hometownsource.com· 3 days agoReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable
Q1 2024 AbbVie Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoTotal net revenues were $12.3 billion, approximately $400 million ahead of our expectations. This overachievement was driven by our ex-Humira growth platform, which delivered revenue growth ...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 3 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks· 5 days agoThe first-quarter 2024 reporting cycle of the Medical sector is about to pick up pace this week. The...
Artisan International Fund Q1 2024 Commentary
Seeking Alpha· 5 days agoArtisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of ...
AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises
Morningstar· 3 days agoBy Dean Seal AbbVie raised its annual adjusted earnings guidance after revenue unexpectedly rose in the first quarter as lower sales of Humira were offset with gains elsewhere. The drugmaker now expects adjusted earnings, which strip out
